ATF3 prevents retinal ganglion cell apoptosis and mitigates microglia-mediated neuroinflammation in retinal ischemia–reperfusion injury
ATF3 overexpression may be a potential therapeutic strategy for the management of retinal ischemia-reperfusion-associated neurodegenerative diseases.
Authors
- Wenye Cao (ORCID: https://orcid.org/0000-0003-1781-0555)
- Yiqiao Xing (ORCID: https://orcid.org/0000-0001-5534-1951)
- Xuejun He (ORCID: https://orcid.org/0000-0001-7183-4860)
- Tian Tian
- Zhiyi Wang (ORCID: https://orcid.org/0000-0002-9349-4059)
- Ning Yang (ORCID: https://orcid.org/0000-0003-3036-0202)
- Wenxi Zhang (ORCID: https://orcid.org/0009-0003-2775-6473)
- Ningzhi Zhang (ORCID: https://orcid.org/0000-0002-9570-4726)
Institutions
- Yangtze University (CN)
- Sir Run Run Shaw Hospital (CN)
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
- He Eye Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1671204
- Citations
- 1
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.84